FDA approves new protease inhibitor for HIV infection.
Miller
J L
JL
D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004338:Drug Combinations; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000378:metabolism / Q000627:therapeutic use*; D019438:Ritonavir / Q000378:metabolism / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir